Adhera Therapeutics, Inc. (ATRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
Adhera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Net Income | -4.49 | -2.11 | -6.35 | -3.77 | -11.98 | -16.76 | Upgrade
|
| Depreciation & Amortization | - | - | - | - | 0.08 | 0.33 | Upgrade
|
| Other Amortization | 1.79 | 1.81 | 0.4 | 0.84 | 0.36 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.06 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.12 | 5.18 | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.01 | 0.77 | 1.45 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.03 | 0.07 | Upgrade
|
| Other Operating Activities | 1.36 | -1.31 | 5.28 | 0.94 | 0.35 | 1.49 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | 0.02 | -0.12 | Upgrade
|
| Change in Inventory | - | - | - | - | -0.24 | -0.2 | Upgrade
|
| Change in Accounts Payable | 0.1 | 0.07 | 0.09 | 0.85 | 1.13 | -0.7 | Upgrade
|
| Change in Other Net Operating Assets | 0.43 | 0.14 | -0.09 | 0.54 | -0.43 | -0.45 | Upgrade
|
| Operating Cash Flow | -0.71 | -1.42 | -0.67 | -0.59 | -8.74 | -9.61 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.07 | Upgrade
|
| Investing Cash Flow | - | - | - | - | - | -0.07 | Upgrade
|
| Short-Term Debt Issued | - | 2.3 | 0.84 | 0.65 | 5.68 | - | Upgrade
|
| Total Debt Issued | 0.89 | 2.3 | 0.84 | 0.65 | 5.68 | - | Upgrade
|
| Short-Term Debt Repaid | - | -0.58 | - | - | - | -0.14 | Upgrade
|
| Total Debt Repaid | -0.21 | -0.58 | - | - | - | -0.14 | Upgrade
|
| Net Debt Issued (Repaid) | 0.67 | 1.72 | 0.84 | 0.65 | 5.68 | -0.14 | Upgrade
|
| Repurchase of Common Stock | - | -0 | - | - | - | -0.25 | Upgrade
|
| Other Financing Activities | -0.06 | -0.35 | -0.1 | -0.11 | -0.71 | - | Upgrade
|
| Financing Cash Flow | 0.61 | 1.37 | 0.74 | 0.54 | 4.87 | 13.5 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -0.1 | -0.04 | 0.08 | -0.05 | -3.87 | 3.81 | Upgrade
|
| Free Cash Flow | -0.71 | -1.42 | -0.67 | -0.59 | -8.74 | -9.69 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -3467.46% | -12743.42% | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.61 | -1.02 | -1.08 | -16.12 | -17.87 | Upgrade
|
| Cash Interest Paid | - | 0.09 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | 0.56 | -6.06 | 9.14 | 2.31 | -2.43 | -7.27 | Upgrade
|
| Unlevered Free Cash Flow | 0.77 | -5.9 | 9.64 | 2.58 | -2.38 | -7.29 | Upgrade
|
| Change in Net Working Capital | -1.57 | 4.89 | -10.06 | -3.85 | -3.15 | 2.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.